PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 138 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,570,354 | -25.0% | 154,098 | +3.4% | 0.02% | -39.4% |
| Q1 2023 | $3,426,816 | +1178.7% | 148,992 | +368.3% | 0.03% | +1550.0% |
| Q3 2022 | $268,000 | -29.5% | 31,814 | -33.8% | 0.00% | -50.0% |
| Q2 2022 | $380,000 | +16.9% | 48,032 | +250.6% | 0.00% | +33.3% |
| Q1 2022 | $325,000 | +45.1% | 13,700 | +174.0% | 0.00% | +50.0% |
| Q2 2021 | $224,000 | -81.8% | 5,000 | -95.1% | 0.00% | -95.5% |
| Q2 2019 | $1,233,000 | +309.6% | 101,800 | +324.2% | 0.04% | +340.0% |
| Q1 2019 | $301,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |